日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.

PARP抑制剂talazoparib在滑膜肉瘤中的新型治疗潜力及其与ATR抑制剂的联合作用。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04422-5
Honda Noritaka, Taniguchi Hirokazu, Ono Sawana, Hayashi Fumiko, Imamura Erika, Gyotoku Hiroshi, Takemoto Shinnosuke, Takazono Takahiro, Ishimoto Hiroshi, Sakamoto Noriho, Obase Yasushi, Masutani Mitsuko, Nishino Tomoya, Mukae Hiroshi
滑膜肉瘤
肿瘤
ATR
PARP
发表日期：2026
文献求助 收藏

Lenvatinib for patients with previously treated advanced thymic carcinoma in real-world settings

在真实世界中，乐伐替尼用于既往接受过治疗的晚期胸腺癌患者

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105301
Takagi, K; Saito, G; Tanaka, H; Kubo, S; Shukuya, T; Tsugitomi, R; Sasaki, T; Oba, T; Mamesaya, N; Yamanaka, T; Tachihara, M; Gyotoku, H; Nagashima, H; Tamiya, M; Kanemura, H; Tozuka, T; Furuta, M; Sakata, S; Mouri, A; Miwa, H; Kawachi, H; Ninomiya, T; Nagai, Y; Ogino, H; Ito, K; Tamura, Y; Tokito, T; Ishihara, M; Ashinuma, H; Tsukita, Y; Kogure, Y; Masuda, T; Suzuki, T
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET

一项评估卡铂联合白蛋白紫杉醇治疗初治晚期或复发性胸腺上皮肿瘤疗效和安全性的II期临床试验：Nab-TET方案

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-2025-1110
Hayashi, Fumiko; Matsuo, Midori; Takemoto, Shinnosuke; Ogata, Ryosuke; Umeyama, Yasuhiro; Nakatomi, Katsumi; Ikeda, Takaya; Sugasaki, Nanae; Doi, Seiji; Kitazaki, Takeshi; Akagi, Kazumasa; Tomono, Hiromi; Honda, Noritaka; Dotsu, Yosuke; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Fukuda, Minoru; Soda, Hiroshi; Mukae, Hiroshi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Effectiveness of direct needle puncture for complete hepaticojejunostomy anastomotic stricture after pancreaticoduodenectomy (with video)

直接针刺治疗胰十二指肠切除术后肝空肠吻合口狭窄的有效性（附视频）

期刊:DEN Open
影响因子:1.5
doi:10.1002/deo2.396
Soga, Koichi; Hayakawa, Fuki; Fujiwara, Takeshi; Gyotoku, Yoshinori; Kusano, Yumi; Kobori, Ikuhiro; Tamano, Masaya
发表日期：2025
文献求助 收藏

Immunoglobulin G4-Related Disease of the Sternoclavicular Joint: A Case Report

免疫球蛋白G4相关胸锁关节疾病：病例报告

期刊:Clinical Case Reports
影响因子:0.6
doi:10.1002/ccr3.70366
Mizuta, Remi; Takemoto, Shinnosuke; Ozasa, Mutsumi; Ono, Sawana; Fukuda, Takahito; Tagawa, Ryuta; Hayashi, Fumiko; Akagi, Kazumasa; Tomono, Hiromi; Taniguchi, Hirokazu; Matsuo, Midori; Gyotoku, Hiroshi; Takazono, Takahiro; Ishimoto, Hiroshi; Sakamoto, Noriho; Matsumoto, Keitaro; Obase, Yasushi; Nishino, Tomoya; Mukae, Hiroshi
免疫/内分泌
发表日期：2025
文献求助 收藏

Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)

雷莫芦单抗和多西他赛治疗既往接受过铂类药物治疗的非小细胞肺癌合并恶性胸腔积液患者的 II 期研究（PLEURAM 研究）

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-508
Takemoto, Shinnosuke; Fukuda, Minoru; Ogata, Ryosuke; Senju, Hiroaki; Sugasaki, Nanae; Nakatomi, Katsumi; Tomono, Hiromi; Suyama, Takayuki; Sasaki, Eisuke; Matsuo, Midori; Akagi, Kazumasa; Hayashi, Fumiko; Dotsu, Yosuke; Ono, Sawana; Honda, Noritaka; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Ikeda, Takaya; Nagashima, Seiji; Soda, Hiroshi; Kinoshita, Akitoshi; Mukae, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma

人类γδ T细胞介导的抗恶性胸膜间皮瘤细胞毒性的三种不同机制

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1058838
Umeyama, Yasuhiro; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Senju, Hiroaki; Tomono, Hiromi; Takemoto, Shinnosuke; Yamaguchi, Hiroyuki; Tagod, Mohammed S O; Iwasaki, Masashi; Tanaka, Yoshimasa; Mukae, Hiroshi
T细胞
T细胞
细胞生物学
毒理研究
免疫/内分泌
发表日期：2023
文献求助 收藏

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer

对肺癌患者出现类固醇难治性免疫相关不良事件时，可采用二线免疫抑制剂治疗。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03528-x
Ogusu, Shinsuke; Harutani, Yuhei; Tozuka, Takehiro; Saito, Ryota; Koyama, Junji; Sakamoto, Hiroaki; Sonoda, Tomoaki; Tsuchiya-Kawano, Yuko; Oba, Tomohiro; Kudo, Keita; Gyotoku, Hiroshi; Nakatomi, Katsumi; Ariyasu, Ryo
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Pan-HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK-rearranged lung cancer

泛HER抑制剂可克服ALK重排肺癌中NRG1/HER3激活引起的劳拉替尼耐药性

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.15579
Hirokazu Taniguchi,Kazumasa Akagi,Yosuke Dotsu,Tadaaki Yamada,Sawana Ono,Erika Imamura,Hiroshi Gyotoku,Shinnosuke Takemoto,Hiroyuki Yamaguchi,Triparna Sen,Seiji Yano,Hiroshi Mukae
肺癌
肿瘤
ALK
发表日期：2023
文献求助 收藏

Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets

日本人群胸腺上皮肿瘤的基因图谱：一项探讨潜在治疗靶点的探索性研究

期刊:Translational Lung Cancer Research
影响因子:4
doi:10.21037/tlcr-22-794
Midori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Norihito Kaku, Chikako Senju, Hiroaki Senju, Erika Imamura, Shinnosuke Takemoto, Kazuko Yamamoto, Noriho Sakamoto, Yasushi Obase, Tomoshi Tsuchiya, Minoru Fukuda, Hiroshi Soda, Kazuto Ashizawa, Junya Fukuoka, Ta
肿瘤
发表日期：2023
文献求助 收藏